Press Releases 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Eagle Pharmaceuticals, Inc. Reports Second Quarter 2017 Results 8/9/17 Eagle Pharmaceuticals, Inc. to Discuss Second Quarter 2017 Financial Results on August 9, 2017 7/31/17 Eagle Pharmaceuticals Receives Complete Response Letter from FDA on RYANODEX for Exertional Heat Stroke Application 7/26/17 Eagle Pharmaceuticals, Inc. Issues Statement Regarding RYANODEX Application PDUFA Date for Exertional Heat Stroke 7/25/17 Eagle Pharmaceuticals, Inc. to Present at Investor Conferences in June 5/31/17 Eagle Pharmaceuticals Appoints Pete A. Meyers as Chief Financial Officer 5/15/17 Eagle Pharmaceuticals, Inc. to Present at Bank of America Merrill Lynch 2017 Health Care Conference 5/10/17 Eagle Pharmaceuticals, Inc. Reports First Quarter 2017 Results 5/8/17 Eagle Pharmaceuticals, Inc. to Discuss First Quarter 2017 Financial Results on May 8, 2017 4/25/17 Eagle Pharmaceuticals, Inc. to Present at 42nd Annual Deutsche Bank Health Care Conference 4/24/17 Pagination First page Previous page Page 1 Current page 2 Page 3 Page 4 Next page Last page
